News Minimalist logo

News Minimalist

All news ranked by significance

Wegovy's long trial shows sustained 10% weight loss, heart protection

CNN — May 14, 2024, 12:00 AM UTC

Summary: New analyses of the weight-loss drug Wegovy show an average weight loss of over 10% sustained for up to four years. More than 25,000 Americans start Wegovy weekly, with 15 million using GLP-1 receptor agonists. The drug reduces heart risk and may protect the heart beyond weight loss alone. Side effects are mainly gastrointestinal, with no new safety concerns after four years. Wegovy's benefits extend beyond weight loss.

Full article

Article metrics
Significance5.1
Scale & Impact0.0
Positivity7.0
Credibility8.0
What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

  1. [4.7]
    New therapy targets brain's appetite center for weight loss (News-Medical.Net)
    154d 8h
    Source
  2. [4.4]
    Dual-action drug MK-801 doubles weight loss in mice (Inside Precision Medicine)
    154d 11h
    Source
  3. [2.9]
    New weight loss shot CT-388 shows promising results (Daily Mail)
    154d 11h
    Source
  4. [5.5]
    Roche's CT-388 weight loss drug shows promising trial results (CNBC)
    154d 13h

    ScoresSource
  5. [5.6]
    Wegovy sustains weight loss for at least 4 years (WIRED)
    154d 16h

    ScoresSource
  6. [2.1]
    Novo Nordisk to study Ozempic's effects on alcohol consumption (CNN)
    155d 5h
    Source
  7. [5.5]
    Semaglutides improve heart health by 20% beyond weight loss (The Guardian)
    155d 17h

    ScoresSource
  8. [4.5]
    Personalized semaglutide dosing aids sustainable weight loss (News-Medical.Net)
    156d 9h
    Source
  9. [3.2]
    Ozempic reduces heart attack risk, may help fight other diseases (Daily Mail)
    156d 9h
    Source
  10. [5.2]
    Semaglutide (Ozempic) shows potential for treating addiction and dementia (The Guardian)
    156d 10h

    ScoresSource
  11. [3.0]
    New weight loss jab retatrutide shows promising results (Daily Mail)
    156d 11h
    Source
  12. [3.1]
    "Book 'Magic Pill' delves into weight loss drug Ozempic." (Mint)
    156d 14h
    Source
  13. [5.8]
    Semaglutide reduces heart attack risk by 20% (Irish Examiner)
    156d 16h

    ScoresSource
  14. [5.8]
    Semaglutide reduces heart attack risk by 20% (The Guardian)
    157d 3h

    ScoresSource
  15. [4.2]
    Wegovy trial shows 10% weight loss maintained after 4 years (CTV News)
    157d 3h
    Source
  16. [4.6]
    Semaglutide reduces need for diuretics in heart failure patients (Diagnostic and Interventional Cardiology)
    157d 10h
    Source
  17. [3.9]
    Semaglutide improves heart failure symptoms and reduces diuretic dose (News-Medical.Net)
    157d 10h
    Source
  18. [4.5]
    Author suggests India learn from Japan's diet success, caution on weight-loss drugs (BusinessLine)
    157d 23h
    Source
  19. [2.2]
    1 in 8 US adults use GLP-1 drugs like Ozempic (CNN)
    160d 16h
    Source
  20. [3.1]
    Wegovy weight loss drug now available in Canada (CTV News Kitchener)
    162d 6h
    Source